Domov › Nemalobunkový karcinóm pľúc › Washington › Seattle
Klinické štúdie Nemalobunkový karcinóm pľúc v meste Seattle, WA
53 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Seattle a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 2/3
- Fred Hutchinson Cancer Center. /ID# 277939, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Prebieha náborFáza 3
- Swedish Cancer Institute ( Site 0143), Seattle
- St. Joseph Medical Center Hematology and Oncology - Silverdale ( Site 0192), Silverdale · 17 míľ odtiaľ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Prebieha náborFáza 3
- Swedish Medical Center-First Hill, Seattle
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Prebieha náborFáza 1
- Fred Hutchinson Cancer Center, Seattle
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Prebieha náborFáza 3
- University of Washington - Fred Hutchinson Cancer Center, Seattle
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Prebieha náborFáza 2
- Swedish Cancer Institute, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Prebieha náborObservačná štúdia
- Fred Hutchinson Cancer Center, Seattle
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Prebieha náborFáza 2
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Swedish Medical Center, Seattle
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Swedish Medical Center, Seattle
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Research Site, Seattle
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Prebieha náborFáza 3
- Local Institution - 0508, Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Prebieha náborFáza 1/2
- University of Washington Fred Hutchinson Cancer Center, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- University of Washington Fred Hutchinson, Seattle
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 3
- Research Site, Seattle
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
Prebieha náborFáza 2
- Fred Hutchison Cancer Center, Seattle
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Prebieha náborFáza 3
- Clinical Study Site, Seattle
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Prebieha náborFáza 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Prebieha náborFáza 2
- University of Washington (Data Collection Only), Seattle
A Study of KK2269 in Adult Participants With Solid Tumors
Prebieha náborFáza 1
- University of Washington, Seattle
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Prebieha náborFáza 1
- Fred Hutchinson Cancer Center, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Prebieha náborFáza 1
- Fred Hutchinson Cancer Center, Seattle
SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- Fred Hutchinson Cancer Center, Seattle
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
SMP-3124LP in Adults With Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of Washington, Seattle
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
Prebieha nábor
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Prebieha náborFáza 1/2
- Fred Hutchinson Cancer Center, Seattle
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- Fred Hutchinson Cancer Center, Seattle
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Prebieha náborFáza 1/2
- Swedish Cancer Institute, Seattle
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Prebieha náborFáza 1
- University Of Washington, Seattle
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Prebieha náborFáza 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Prebieha náborFáza 2
- Seattle Cancer Care Alliance, Seattle
Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial
Prebieha nábor
- Fred Hutch/University of Washington Cancer Consortium, Seattle
SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer
Prebieha náborFáza 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Prebieha náborFáza 1/2
- Fred Hutchinson Cancer Center, Seattle
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- FHCC at Northwest Hospital, Seattle
- a 1 ďalších
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Prebieha náborFáza 1
- Fred Hutchinson Cancer Center, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- Virginia Mason Medical Center, Seattle
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Swedish Medical Center-First Hill, Seattle
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Swedish Medical Center-First Hill, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Prebieha náborFáza 1/2
- Virginia Mason Medical Center, Seattle
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Kaiser Permanente Washington, Seattle
- Swedish Medical Center-First Hill, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Prebieha náborFáza 1/2
- Fred Hutch Cancer Center, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
Prebieha náborFáza 1
- Fred Hutchinson Cancer Center, Seattle
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- Swedish Health Sciences, Seattle
- Research Site, Seattle
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Prebieha náborFáza 2
- Fred Hutchinson Cancer Center, Seattle
Štúdie Nemalobunkový karcinóm pľúc v iných mestách
- Houston, TX145 štúdií
- New York City, NY121 štúdií
- Arlington, VA104 štúdií
- Nashville, TN97 štúdií
- Boston, MA90 štúdií
- Los Angeles, CA87 štúdií
- St. Louis, MO73 štúdií
- Chicago, IL61 štúdií
- Baltimore, MD60 štúdií
- San Antonio, TX59 štúdií
- Columbus, OH57 štúdií
- Washington, DC55 štúdií
Iné štúdie v Seattle
- Rakovina (všetky typy)49 štúdií
- Rakovina prostaty42 štúdií
- Akútna myeloidná leukémia41 štúdií
- Rakovina prsníka39 štúdií
- Metastatická rakovina39 štúdií
- Kolorektálny karcinóm34 štúdií
- Rakovina pľúc33 štúdií
- Rakovina vaječníkov30 štúdií
- Mnohonásobný myelóm22 štúdií
- Rakovina močového mechúra21 štúdií
- Myelodysplastické syndrómy21 štúdií
- Akútna lymfoblastová leukémia21 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.